Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitor

Supporting evidence

• Evaluation report

• Appraisal consultation committee papers (PDF 8.73 MB)

  Published:

  26 October 2016

• Final appraisal determination committee papers (PDF 1.34 MB)

  Published:

  26 October 2016